During the past decade, Maccabi Healthcare Services conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maccabi Healthcare Services" #1 sponsor was "Assuta Hospital Systems" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Maccabi Healthcare Services, Israel" with 2 trials sponsored, "Bait Balev Hospital" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maccabi Healthcare Services" #1 collaborator was "Maccabi Healthcare Services, Israel" with 2 trials as a collaborator, "Daewon Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Rabin Medical Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Maccabi Healthcare Services" are "Hepatitis C, Chronic" (2 trials), "Atrial Fibrillation" (1 trials), "Caloric Restriction" (1 trials), "Cerebrovascular Atherosclerosis" (1 trials) and "Cerebrovascular Disease" (1 trials). Many other conditions were trialed in "Maccabi Healthcare Services" in a lesser frequency.

Most popular intervention types in "Maccabi Healthcare Services" are "Drug" (5 trials), "Other" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "TECH: Tablet Enhancement of Cognition and Health" (2 trials), "peginterferon alfa-2a [Pegasys]" (2 trials), "0.3% Ciprofloxacin Ear Drops" (1 trials), "0.3% Ciprofloxacin Foam Otic Cipro" (1 trials) and "COPEGUS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maccabi Healthcare Services" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Maccabi Healthcare Services". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 8 completed trials in Maccabi Healthcare Services, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maccabi Healthcare Services, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".